Evaluation of serum level of lymphoid enhancer-binding factor-1 and its relation with clinico-hematological and prognostic parameters in pediatric patients with acute lymphoblastic leukemia
BACKGROUND: Acute lymphoblastic leukemia (ALL) is a heterogeneous disorder characterized by the proliferation of immature lymphoid cells that accumulate in the bone marrow, peripheral blood, and extramedullary sites, causing the clinical manifestations of the disease. Lymphoid enhancer-binding facto...
Main Authors: | Zeena Tariq Ahmed, Abeer Anwer Ahmed |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2022-01-01
|
Series: | Iraqi Journal of Hematology |
Subjects: | |
Online Access: | http://www.ijhonline.org/article.asp?issn=2072-8069;year=2022;volume=11;issue=1;spage=45;epage=50;aulast=Ahmed |
Similar Items
-
Prognostic Significance of Lymphoid Enhancer-Binding Factor-1 Expression in Egyptian Adult B-Acute Lymphocytic Leukemia Patients
by: Rabab M. Aly, et al.
Published: (2015-02-01) -
High lymphoid enhancer- binding factor-1 expression is associated with disease progression and poor prognosis in chronic lymphocytic leukemia
by: Felix Erdfelder, et al.
Published: (2010-05-01) -
Oncogenic and Tumor Suppressor Functions for Lymphoid Enhancer Factor 1 in E2a-/- T Acute Lymphoblastic Leukemia
by: Tiffany Carr, et al.
Published: (2022-03-01) -
Treatment of Acute Lymphoid Leukemia Refractory to Classic First-Line and Rescue Protocols
by: Flávia Tobaldini Russo, et al.
Published: (2020-04-01) -
T-lymphoid/myeloid mixed phenotype acute leukemia and early T-cell precursor lymphoblastic leukemia similarities with NOTCH1 mutation as a good prognostic factor
by: Noronha EP, et al.
Published: (2019-05-01)